Skip to main content
Fig. 3 | Journal of Ovarian Research

Fig. 3

From: Activation of PI3K/AKT/mTOR signaling axis by UBE2S inhibits autophagy leading to cisplatin resistance in ovarian cancer

Fig. 3

Correlation of UBE2S with platinum resistance in ovarian cancer. A A scatter plot of the difference in the expression level of UBE2S in platinum-sensitive and platinum-resistant tissues of ovarian cancer in the TCGA data set. B Based on the KM database, the overall survival curve of patients in the low-expression group and high-expression group of UBE2S gene in platinum-resistant chemotherapy patients. The blue line indicates platinum resistance, and the red line indicates platinum sensitivity. C The immunohistochemical staining results of 63 patients with ovarian cancer were collected clinically. The fields of view are 100 × and 200 × respectively. D Histogram of immunohistochemical scores and the statistical table of UBE2S staining expression of patients

Back to article page

Journal of Ovarian Research

ISSN: 1757-2215

Contact us